《盈警響號》維他奶(00345.HK)料年度盈轉虧 蝕最多1.72億元
維他奶國際(00345.HK)預計,截至今年3月31日止財政年度股權持有人應佔綜合財務業績將錄得虧損介乎1.51億元至1.72億元,去年同期股權持有人應佔溢利為5.48億元。
公司指,於內地銷售於第二財季度曾錄得顯著下跌,但下半財年度內大幅回升,令跌幅大幅收窄。 至於其他營運單位收入在整個財政年度均錄得增長。盈利方面,下半財年雖然較去年同期比較下跌,但跌幅較上半財年收窄。
公司解釋指,預期將錄得虧損主要因為內地銷售在夏天旺季月份錄得顯著下跌;本財政年度獲政府疫情補貼金額為1,980萬元,去年同期為2.25億元;及將深圳廠房搬遷至東莞現代化廠房所產生的較大的非經常性開支及資產減值。
公司預期,透過強化產品創新、廣告宣傳及推廣投資、市場發展策略及銷售,同時加強與消費者溝通,2022/23財年公司銷售及盈利將持續回升並回復按年盈利增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.